A novel splicing mutation of the CYLD gene in a Taiwanese family with multiple familial trichoepithelioma

Clin Exp Dermatol. 2009 Jan;34(1):77-80. doi: 10.1111/j.1365-2230.2008.02870.x.

Abstract

Multiple familial trichoepithelioma (MFT) is an autosomal dominant disease characterized by numerous skin-coloured papules on the central face. Mutations in the CYLD gene, which is also the gene responsible for familial cylindromatosis, have been reported recently. Recent studies indicate that CYLD is a tumour-suppressor gene. The CYLD protein is a negative regulator of the activation of transcription factor nuclear factor-kappaB, and loss of CYLD contributes to oncogenesis. We report a novel splicing mutation (IVS12 + 1 G-->A) in the CYLD gene in a Taiwanese pedigree with MFT, and discuss new developments in treatment options.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Alternative Splicing*
  • Child
  • DNA Mutational Analysis
  • Deubiquitinating Enzyme CYLD
  • Facial Neoplasms / genetics*
  • Facial Neoplasms / pathology
  • Female
  • Genes, Tumor Suppressor
  • Heterozygote
  • Humans
  • Mutation*
  • Neoplasms, Basal Cell / genetics*
  • Neoplasms, Basal Cell / pathology
  • Pedigree
  • Taiwan
  • Tumor Suppressor Proteins / genetics*

Substances

  • Tumor Suppressor Proteins
  • CYLD protein, human
  • Deubiquitinating Enzyme CYLD